United-Guardian, Inc. (NASDAQ:UG) released its earnings results on Thursday. The company reported $0.24 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. United-Guardian had a net margin of 28.28% and a return on equity of 25.48%. The company had revenue of $3.18 million during the quarter.
Shares of United-Guardian (NASDAQ:UG) opened at $17.00 on Friday. United-Guardian has a 12-month low of $13.75 and a 12-month high of $21.25. The stock has a market cap of $78.10, a price-to-earnings ratio of 21.80 and a beta of 0.17.
An institutional investor recently raised its position in United-Guardian stock. Northern Trust Corp raised its holdings in United-Guardian, Inc. (NASDAQ:UG) by 5.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,763 shares of the company’s stock after purchasing an additional 592 shares during the quarter. Northern Trust Corp owned 0.23% of United-Guardian worth $167,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 22.63% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/11/11/united-guardian-inc-ug-issues-earnings-results.html.
Several research analysts have recently commented on UG shares. ValuEngine upgraded shares of United-Guardian from a “sell” rating to a “hold” rating in a research note on Thursday, July 27th. TheStreet upgraded shares of United-Guardian from a “c” rating to a “b” rating in a research note on Thursday, August 24th.
United-Guardian Company Profile
United-Guardian, Inc manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products.
Receive News & Ratings for United-Guardian Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian Inc. and related companies with MarketBeat.com's FREE daily email newsletter.